These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24565897)

  • 1. Carboxyl-terminal multi-site phosphorylation regulates internalization and desensitization of the human sst2 somatostatin receptor.
    Lehmann A; Kliewer A; Schütz D; Nagel F; Stumm R; Schulz S
    Mol Cell Endocrinol; 2014 Apr; 387(1-2):44-51. PubMed ID: 24565897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural determinants of agonist-selective signaling at the sst(2A) somatostatin receptor.
    Nagel F; Doll C; Pöll F; Kliewer A; Schröder H; Schulz S
    Mol Endocrinol; 2011 May; 25(5):859-66. PubMed ID: 21330405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of octreotide and pasireotide on somatostatin receptor internalization and trafficking in vitro.
    Lesche S; Lehmann D; Nagel F; Schmid HA; Schulz S
    J Clin Endocrinol Metab; 2009 Feb; 94(2):654-61. PubMed ID: 19001514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pasireotide and octreotide stimulate distinct patterns of sst2A somatostatin receptor phosphorylation.
    Pöll F; Lehmann D; Illing S; Ginj M; Jacobs S; Lupp A; Stumm R; Schulz S
    Mol Endocrinol; 2010 Feb; 24(2):436-46. PubMed ID: 20051480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pasireotide and octreotide antiproliferative effects and sst2 trafficking in human pancreatic neuroendocrine tumor cultures.
    Mohamed A; Blanchard MP; Albertelli M; Barbieri F; Brue T; Niccoli P; Delpero JR; Monges G; Garcia S; Ferone D; Florio T; Enjalbert A; Moutardier V; Schonbrunn A; Gerard C; Barlier A; Saveanu A
    Endocr Relat Cancer; 2014 Oct; 21(5):691-704. PubMed ID: 25012983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-dependent mechanisms of sst2A receptor trafficking: role of site-specific phosphorylation and receptor activation in the actions of biased somatostatin agonists.
    Kao YJ; Ghosh M; Schonbrunn A
    Mol Endocrinol; 2011 Jun; 25(6):1040-54. PubMed ID: 21493671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of threonine 333 regulates trafficking of the human sst5 somatostatin receptor.
    Petrich A; Mann A; Kliewer A; Nagel F; Strigli A; Märtens JC; Pöll F; Schulz S
    Mol Endocrinol; 2013 Apr; 27(4):671-82. PubMed ID: 23418396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct phosphorylation sites in the SST2A somatostatin receptor control internalization, desensitization, and arrestin binding.
    Liu Q; Dewi DA; Liu W; Bee MS; Schonbrunn A
    Mol Pharmacol; 2008 Feb; 73(2):292-304. PubMed ID: 17981995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The third intracellular loop of the human somatostatin receptor 5 is crucial for arrestin binding and receptor internalization after somatostatin stimulation.
    Peverelli E; Mantovani G; Calebiro D; Doni A; Bondioni S; Lania A; Beck-Peccoz P; Spada A
    Mol Endocrinol; 2008 Mar; 22(3):676-88. PubMed ID: 18096696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porcine somatostatin receptor 2 displays typical pharmacological sst2 features but unique dynamics of homodimerization and internalization.
    Durán-Prado M; Bucharles C; Gonzalez BJ; Vázquez-Martínez R; Martínez-Fuentes AJ; García-Navarro S; Rhodes SJ; Vaudry H; Malagón MM; Castaño JP
    Endocrinology; 2007 Jan; 148(1):411-21. PubMed ID: 17053026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of beta-Arrestin 1 with the type 1A angiotensin II receptor involves phosphorylation of the receptor carboxyl terminus and correlates with receptor internalization.
    Qian H; Pipolo L; Thomas WG
    Mol Endocrinol; 2001 Oct; 15(10):1706-19. PubMed ID: 11579203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serine residues 338 and 339 in the carboxyl-terminal tail of the type II gonadotropin-releasing hormone receptor are critical for beta-arrestin-independent internalization.
    Ronacher K; Matsiliza N; Nkwanyana N; Pawson AJ; Adam T; Flanagan CA; Millar RP; Katz AA
    Endocrinology; 2004 Oct; 145(10):4480-8. PubMed ID: 15205374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitro.
    Ibáñez-Costa A; Rivero-Cortés E; Vázquez-Borrego MC; Gahete MD; Jiménez-Reina L; Venegas-Moreno E; de la Riva A; Arráez MÁ; González-Molero I; Schmid HA; Maraver-Selfa S; Gavilán-Villarejo I; García-Arnés JA; Japón MA; Soto-Moreno A; Gálvez MA; Luque RM; Castaño JP
    J Endocrinol; 2016 Nov; 231(2):135-145. PubMed ID: 27587848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Phosphorylation Sites Regulating sst3 Somatostatin Receptor Trafficking.
    Lehmann A; Kliewer A; Günther T; Nagel F; Schulz S
    Mol Endocrinol; 2016 Jun; 30(6):645-59. PubMed ID: 27101376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A transplantable phosphorylation probe for direct assessment of G protein-coupled receptor activation.
    Kliewer A; Mann A; Petrich A; Pöll F; Schulz S
    PLoS One; 2012; 7(6):e39458. PubMed ID: 22745760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists.
    Cescato R; Schulz S; Waser B; Eltschinger V; Rivier JE; Wester HJ; Culler M; Ginj M; Liu Q; Schonbrunn A; Reubi JC
    J Nucl Med; 2006 Mar; 47(3):502-11. PubMed ID: 16513620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor signaling and endocytosis are differentially regulated by somatostatin analogs.
    Liu Q; Cescato R; Dewi DA; Rivier J; Reubi JC; Schonbrunn A
    Mol Pharmacol; 2005 Jul; 68(1):90-101. PubMed ID: 15855408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of somatostatin SST(2) receptor internalization in vivo after intravenous SOM230 application in the AR42J animal tumor model.
    Waser B; Cescato R; Tamma ML; Maecke HR; Reubi JC
    Eur J Pharmacol; 2010 Oct; 644(1-3):257-62. PubMed ID: 20643121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homologous and heterologous regulation of somatostatin receptor 2.
    Elberg G; Hipkin RW; Schonbrunn A
    Mol Endocrinol; 2002 Nov; 16(11):2502-14. PubMed ID: 12403839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a Ser/Thr cluster in the C-terminal domain of the human prostaglandin receptor EP4 that is essential for agonist-induced beta-arrestin1 recruitment but differs from the apparent principal phosphorylation site.
    Neuschäfer-Rube F; Hermosilla R; Rehwald M; Rönnstrand L; Schülein R; Wernstedt C; Püschel GP
    Biochem J; 2004 May; 379(Pt 3):573-85. PubMed ID: 14709160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.